Prostate Cancer Clinical Trial

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Summary

The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.

View Full Description

Full Description

The CyberKnife Robotic Radiosurgery System is a unique radiosurgical system capable of treating tumors anywhere in the body noninvasively and with sub-millimeter accuracy. The CyberKnife System delivers radiation using a precise targeting methodology allowing a focal treatment margin around the target, thus limiting the volume of adjacent tissue receiving high doses radiation. This in turn allows the delivery of high doses of radiation to the prostate over a short series of treatments.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient must be at least 18 years of age
Histologically proven prostate adenocarcinoma
Patients belonging in one of the following risk groups:

Low: Clinical Stage (CS) T1b-T2a and Gleason 2-6 and Prostate Specific Antigen (PSA) ≤ 10, or Intermediate: CS T2b and Gleason 2-6 and PSA ≤ 10 or CS T1b-T2b, and Gleason 2-6 and PSA ≤ 20 ng/ml or Gleason 7 and PSA ≤ 10 ng/ml

Prostate volume: ≤ 100 cc
Eastern Cooperative Oncology Group (ECOG) performance status 0-1

Exclusion Criteria:

Prior prostatectomy or cryotherapy of the prostate
Prior radiotherapy to the prostate or lower pelvis
Implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
Chemotherapy for a malignancy in the last 5 years
History of an invasive malignancy (other than this prostate cancer, or basal or squamous skin cancers) in the last 5 years.
Hormone ablation for two months prior to enrollment, or during treatment.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

379

Study ID:

NCT00643994

Recruitment Status:

Completed

Sponsor:

Accuray Incorporated

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 21 Locations for this study

See Locations Near You

St. Joseph's Hospital and Medical Center
Phoenix Arizona, 85013, United States
Scripps Cancer Center - CyberKnife of Southern California at Vista
La Jolla California, 92037, United States
The CyberKnife at Newport Diagnostic Center
Newport Beach California, 92660, United States
Georgetown University
Washington District of Columbia, 20057, United States
Coastal CyberKnife and Radiation Oncology
Fort Pierce Florida, 34982, United States
Jupiter Medical Center & CyberKnife Center of Palm Beach
Jupiter Florida, 33458, United States
Northwest Community Hospital
Arlington Heights Illinois, 60005, United States
Community Cancer Center
Normal Illinois, 61761, United States
Central Baptist Hospital
Lexington Kentucky, 40503, United States
Sinai Hospital of Baltimore
Baltimore Maryland, 21215, United States
Franklin Square Hospital Center
Baltimore Maryland, 21237, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
St. Joseph Mercy Hospital
Ann Arbor Michigan, 48106, United States
Lake Saint Louis Oncology
Saint Louis Missouri, 63367, United States
Saint Louis University
Saint Louis Missouri, 63367, United States
St. Mary's Regional Medical Center
Reno Nevada, 89503, United States
Capital Health
Trenton New Jersey, 08618, United States
Hematology Oncology Associates of Central New York
Syracuse New York, 15057, United States
Virginia Hospital Center
Arlington Virginia, 22205, United States
Swedish Cancer Center
Seattle Washington, 98122, United States
Southwest Washington Medical Center
Vancouver Washington, 98664, United States
Southwest Washington Regional Cancer Center
Vancouver Washington, 98664, United States
ThedaCare Appleton Medical Center
Appleton Wisconsin, 54911, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

379

Study ID:

NCT00643994

Recruitment Status:

Completed

Sponsor:


Accuray Incorporated

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.